Podcasts about Rigby

  • 453PODCASTS
  • 717EPISODES
  • 46mAVG DURATION
  • 5WEEKLY NEW EPISODES
  • Sep 30, 2022LATEST

POPULARITY

20152016201720182019202020212022

Categories



Best podcasts about Rigby

Latest podcast episodes about Rigby

A Little Wray Of Sunshine: Inspirational stories from everyday people
"We can either be a victim in life, or a victor." - Armando Gonzalez

A Little Wray Of Sunshine: Inspirational stories from everyday people

Play Episode Listen Later Sep 30, 2022 34:52


In this episode you will literally feel the excitement and positive energy blasting from your speakers as you hear how Armando Gonzalez channels his passion, energy, and Christian values to motivate his players, as the head coach for the Rigby High School varsity football team. Relocating to Rigby, Idaho from Southern California five years ago, Armando has impacted the lives of countless youth in a positive and constructive way. You will be inspired as he discusses the four core values that are used as a major focal point for their success, which are: 1. Sharpen the axe; 2. Brotherhood; 3. Ride for the brand; and, 4. Championship competitor. "Nothing's a test... just an opportunity to learn and grow." All I can say is hang on! This energetic and fast paced episode will get your heart pumping!

Always Off Brand
“How To Win Ecommerce Search vs Competition!” with Nathan Rigby

Always Off Brand

Play Episode Listen Later Sep 29, 2022 69:16


Search performance and how to win is all that matters for digital marketers on Ecommerce. When people search on Amazon or Google the game is that they find your brand and products! This week, Nathan Rigby Co-Founder of Analytic Index joins us to explain the why and how retailers and anyone in e-commerce needs to win at search turning into sales. What is your market share or share of voice? How much digital shelf do your products have? With less space for search results, you need to know what works and what doesn't quickly. How are you doing compared to key competitors or the category? We play “What's That Keyword?” News segment covering the latest in retail and ecommerce news. Join Scott Ohsman, Summer Jubelirer and Hayley Brucker for years of knowledge and some juicy nuggets. Ecommerce Simplified! Warning, you will learn and be entertained at the same time.  Brought to you by: Athletic Greens. Activate your great deal by going to: https://athleticgreens.com/partner/d35ctoffer-nutrition/en?utm_source=podcast&utm_medium=influencer&utm_campaign=emerging_d35ct__a3878__o27&utm_term=cac__a3878__o27&utm_content=sport__a3878__o27   QUICKFIRE Info:   Website: https://www.quickfirenow.com/ Email the Show: info@quickfirenow.com  Talk to us on Social: Facebook: https://www.facebook.com/quickfireproductions Instagram: https://www.instagram.com/quickfire__/ TikTok: https://www.tiktok.com/@quickfiremarketing LinkedIn : https://www.linkedin.com/company/quickfire-productions-llc/about/   Guest: Nathan Rigby    LinkedIn: https://www.linkedin.com/in/nathan-rigby-ba6aa82/ Website: https://analyticindex.com/   HOSTS: Summer Jubelirer has been in digital commerce and marketing for over 15 years. After spending many years working for digital and ecommerce agencies working with multi-million dollar brands and running teams of Account Managers, she is now the Amazon Manager at OLLY PBC.   LinkedIn https://www.linkedin.com/in/summerjubelirer/   Scott Ohsman has been working with brands for over 27 years in retail, online and has launched over 200 brands on Amazon. Owning his own sales and marketing agency in the Pacific NW, is now VP of Digital Commerce for Quickfire LLC. Scott has been a featured speaker at national trade shows and has developed distribution strategies for many top brands. LinkedIn https://www.linkedin.com/in/scott-ohsman-861196a6/   Hayley Brucker has been working in retail and with Amazon for years. She is currently a Marketing Coordinator at Channel Key LLC. Hayley has extensive experience in digital advertising, both seller and vendor central on Amazon. Hayley is based out of North Carolina and has worked in multiple product categories and has also worked on the brand side and started with Nordstrom on the retail floor.  LinkedIn -https://www.linkedin.com/in/hayley-brucker-1945bb229/   Huge thanks to Cytrus our show theme music “Office Party” available wherever you get your music. Check them out here: Facebook https://www.facebook.com/cytrusmusic Instagram https://www.instagram.com/cytrusmusic/ Twitter https://twitter.com/cytrusmusic SPOTIFY: https://open.spotify.com/artist/6VrNLN6Thj1iUMsiL4Yt5q?si=MeRsjqYfQiafl0f021kHwg APPLE MUSIC https://music.apple.com/us/artist/cytrus/1462321449 “Always Off Brand” is part of the Quickfire Podcast Network and produced by Quickfire LLC.

Common Ground Church Sea Point
Incoming Calls: Jeremiah 29 - Rigby Wallace

Common Ground Church Sea Point

Play Episode Listen Later Sep 26, 2022 41:10


Rigby Wallace takes us through Jeremiah 29 relating to being safe and satisfied in God's sovereign will.

Carlos Amorim CineTvNews
Podcast CineTvNews # 209 Charles Emmanuel Parte 02

Carlos Amorim CineTvNews

Play Episode Listen Later Sep 26, 2022 7:00


O Podcast CineTvNews # 209 esta no ar! Você vai conferir a 2ª parte da entrevista exclusiva com o ator/dublador Charles Emmanuel. Charles é uma das vozes mais atuantes do mercado de dublagem, sendo a voz em português de: Rony Weasley dos filmes Harry Potter, Ben Tennyson na franquia Ben 10, Rigby da série animada Apenas um Show, Mutano de Jovens Titãs, Chiro Takashi de Super Esquadrão dos Macacos Robôs, Nate River (Near) de Death Note, Gowther de Nanatsu No Taizai (Sete pecados capitais),Yang de Yin Yang Yo! e Tenma de Pégaso de Os Cavaleiros do Zodíaco: The Lost Canvas, dentre outros. Para ouvir acesse:

Tri Talking Sport
Tom Rigby Triathlete: Breaking The Tape

Tri Talking Sport

Play Episode Listen Later Sep 21, 2022 50:40


Tom was the third fastest age group athlete at IRONMAN UK last year and in 2019 he was fifth fastest overall and second in his age group at IRONMAN UK earning him a hard-earned and coveted slot for the IRONMAN World Championships in Kona.  Taking up triathlon seven years ago or so, he raced IRONMAN UK in 2015, as a 'one and done' but he is far from done! He did take a bit of a break from racing triathlon to focus on cycling in recent years, where he has also had significant success, however, he missed the fun, camaraderie and friendship of training and racing with his friends and teammates at Tri Preston and so has returned to triathlon. With consistency in training some great training partners and steely determination Tom has enjoyed super fast times and significant improvements in performance in recent years.  2022 was a big year for Tom, despite a late start to his triathlon season, it has been his most successful to date, breaking the tape at IRONMAN 70.3 Cork was the icing on the cake.  In this episode, we get some insight into Tom's approach to training and racing whilst working a forty-hour-a-week job as well as balancing family life with his wife Kerry and two children Evelyn and Sophie – who join us on the show for a couple of minutes.  Together Tom and Kerry are embracing triathlon as a way of life for their family, Tom may be the athlete standing at the start line of a race but Kerry is a key part of Tom's success and together they enjoy and endure the sport of triathlon and long-distance racing as a team. 

Carlos Amorim CineTvNews
Podcast CineTvNews # 208 Charles Emmanuel

Carlos Amorim CineTvNews

Play Episode Listen Later Sep 21, 2022 7:10


O Podcast CineTvNews # 208 esta no ar! Você vai conferir uma entrevista exclusiva com o ator/dublador Charles Emmanuel. Charles é uma das vozes mais atuantes do mercado de dublagem, sendo a voz em português de: Rony Weasley dos filmes Harry Potter, Ben Tennyson na franquia Ben 10,[2] Rigby da série animada Apenas um Show, Mutano de Jovens Titãs, Chiro Takashi de Super Esquadrão dos Macacos Robôs, Nate River (Near) de Death Note, Gowther de Nanatsu No Taizai (Sete pecados capitais),Yang de Yin Yang Yo! e Tenma de Pégaso de Os Cavaleiros do Zodíaco: The Lost Canvas, dentre outros. Para ouvir acesse:

Thrive Lathrop Podcast
Run This Town Conference - Pastor Charles Rigby - Breakout Session II

Thrive Lathrop Podcast

Play Episode Listen Later Sep 16, 2022 34:51


Run This Town Conference - Pastor Charles Rigby - Breakout Session II by Thrive Lathrop

Lift International Church of Zug
God's Sovereign Will - by Rigby Wallace

Lift International Church of Zug

Play Episode Listen Later Sep 11, 2022 48:50


Scripture found in Jeremiah 29

This is Growing Old
54. Celebrating Our Heroes with Kevin Rigby, Master of Ceremonies

This is Growing Old

Play Episode Listen Later Sep 7, 2022 10:42


Each year, the Alliance hosts Heroes in Health, an event to honor individuals and companies making great strides to further research and innovation in aging. Kicking off our 29th annual celebration and here to share his excitement with us is master of ceremonies Kevin Rigby, a champion in the health space and a fierce advocate for aging Americans. Join us on Tuesday, September 20th at the United States Institute of Peace for an evening of generativity and joy as we honor the the heroes who are advance the science of human aging. Click here to learn more or register for our Heroes in Health Celebration.

Keeping it Geekly
Indie Creator Interview #149 w/ John Kissee | Doctor Rigby

Keeping it Geekly

Play Episode Listen Later Sep 3, 2022 34:30


Today we have the opportunity to sit down with John Kissee to break down Doctor Rigby and his experience creating #indiecomics! Be sure to check the links below to stay in touch with his future works! "A thrilling hybrid of weird horror and stylish 60's spy adventure! Shrouded in mystery, Doctor Rigby is an impeccably dressed soldier in a secret, ancient war of magic, monsters, and cosmic madness" Order Doctor Rigby here - bit.ly/doctorrigby Website - www.johnkissee.com --------------------------------------------------------------------------------------------------------------------------- Instagram - https://instagram.com/john_kissee Twitter - https://twitter.com/john_kissee --------------------------------------------------------------------------------------------------------------------------- To stay up to date with my content creation as well as my day-to-day thoughts, feel free to follow my Twitter - https://twitter.com/keepingitgeekly For single issue breakdowns and more be sure to visit my TikTok over at https://tiktok.com/keepingitgeekly Be sure to drop by my Twitch channel where I live stream every Wednesday, Thursday, Friday, and Saturday at 11 PM EST https://twitch.tv/job_for_a_cody My personal Discord -https://discord.gg/vg9zEyKt Intro Music - https://twitter.com/PersyThePianist | http://linktr.ee/PersyNotes Background Music - [FREE] Kota The Friend Type Beat - "Laid Back" - Kota https://www.youtube.com/watch?v=QIY19VZa3FY&t=83s --- Support this podcast: https://anchor.fm/keepingitgeekly/support

CG Wynberg
Safe & Secure in God's Sovereign Will - Rigby Wallace

CG Wynberg

Play Episode Listen Later Aug 30, 2022 49:28


The County 10 Podcast
Coffee Time: Travelling musician Rigby Summer performs in Sinks Canyon tonight, listen in for details

The County 10 Podcast

Play Episode Listen Later Aug 26, 2022 27:47


(Lander, WY) – On today's episode of KOVE 1330 AM / 107.7 FM's Coffee Time, host Vince Tropea chatted with Rigby Summer, a traveling musician who will be performing in Sinks Canyon tonight. Rigby will be playing at the Sawmill Campground in Sinks Canyon as a part of the Lander Creative Arts Club 'Sinks Series,' and the free show will begin at 7:00 PM, with opening act Nightfire. In addition to providing info on tonight's performance, Rigby shared how she ended up a recurring musician in Fremont County despite not living here, the "something special about this place" aspect of Lander's creative community, and some stories from the road. Check out the full Coffee Time interview with Rigby below. Be sure to tune in to Coffee Time every morning at 8:00 AM on KOVE 1330 AM / 107.7 FM, or stream it live right here.

The East Idaho Prepcast
8/25/22 - They Are Who We Thought They Were

The East Idaho Prepcast

Play Episode Listen Later Aug 25, 2022 40:01


Here's the latest East Idaho Prepcast! Sean Kane and Brandon Baney recap impressive opening wins from Rigby, Sugar-Salem and South Fremont in football, and Pocatello's win over Highland in girls soccer.  They also preview the upcoming weekend slate.The East Idaho Prepcast is available on Apple Podcasts, Spotify, Google Podcasts, and wherever else you listen to podcasts.Follow our East Idaho Prepcast team on Twitter: @idahosports, @brandon_baney, @SeanKane182Like our Facebook pageFor more Idaho high school sports coverage, visit www.idahosports.comSubscribe to our YouTube channel

BYU-Idaho Radio
See the production of "Bye Bye Birdie" at Rigby High School tomorrow

BYU-Idaho Radio

Play Episode Listen Later Aug 23, 2022 2:04


Director Megan Anderson shares her anticipations for the upcoming production of "Bye Bye Birdie" in Rigby. Shows are August 24th—August 27th at 7p.m.

That Does Suit Madame, a Podcast about
Episode 81 - It's Joanne Heywood, Miss. Lovelock from Grace & Favour! Are You Being Served Again

That Does Suit Madame, a Podcast about "Are You Being Served?"

Play Episode Listen Later Aug 20, 2022 41:51


The talented and charming Joanne Heywood stopped by the recording studio while on a holiday tour of Northern Mississippi! We learn that Ms. Heywood's first professional acting role was the musical “High Society” (and we even get a bit of her singing on the episode). Which cast member kept giggling during Grace & Favour? AND which actor did all of their own stunts? What could the original AYBS series get away with in comedy that the later sequel couldn't? How does an actor handle an upstaging horse who wants the spotlight? John Inman's lovely codpiece! Was it intimidating to be a new actor on the cast with the very well-known AYBS leads? We learn about Ms. Heywood' 2 years on “First of the Summer Wine”. A connection from Grace & Favour to Gavin and Stacey! What was it like to be an audience member during the filming of the show? She stared in Coronation Street three times, EastEnders, and Emmerdale! We hear accents ranging from East London's “Albert Square” from EastEnders to Proper Northern Lass. What American TV show could be compared to Are You Being Served? The expensive custom nightie made by famous lingerie house Rigby and Peller. Theft in the wardrobe department! And what would have happened to Miss. Lovelock if the series had continued? You can find Joanne Heywood in a Christmas Panto this year. (And yes, Ms. Heywood is unanimous in this). A huge thank you to Joanne for spending time with our podcast. You can find Joanne Heywood on twitter @MsJoanneHeywood Treat yourself to some That Does Suit Madame merch at our Bargain Basement podcast shop at imfree.threadless.com for t-shirts, mugs, tote bags, and more! Leave the show a voicemail at the Peacock Hotline: (662)-PEACOCK (662-732-2625) and find us on Twitter @DoesSuitMadame and #AYBS #AreYouBeingServed #ImFree #Britcom #comedy #ThatDoesSuitMadame #GraceBros #podcast #LGBT #BlackLivesMatter #BBC #AreYouBeingServedAgain #GraceAndFavour #GraceAndFavor #MissLovelock #JoanneHeywood #actor

Hotline League
Playoffs INCOMING! Will TL choke? Toucouille BEST MID NA?! feat. EG Rigby and Peter Dun | HLL 235

Hotline League

Play Episode Listen Later Aug 16, 2022 143:00 Very Popular


00:00:00 Intro - an EVIL episode! 00:18:39 Slowbro wants to talk expectations for EG going into Worlds 00:31:37 Zemelci 00:44:06 Alienware break! 00:47:42 Isthmus's take: Even tho TL/100T/EG are the strongest right now, TL will likely collapse 01:08:00 Michael wants to talk about the pool party broadcast 01:21:00 HLL LIVE ! Grubhub break 01:24:25 arsh's take: Toucouille best mid LCS 01:42:20 Stepbro's take: superteams are overrated 02:01:00 Bluejay wants to talk about GG Danan being let go and why 02:17:40 Outro

Kenan & Kel with Adam & Aaron
Top 10 Chris Potter Moments

Kenan & Kel with Adam & Aaron

Play Episode Listen Later Aug 5, 2022 61:24


One might say it's an easy feat to operate a corner store bodega in Chicago. That one is not Chris Potter. Whether it's dealing with lazy employees or freeloading soda-drinkers, Chris is always ready to quip, rant, and nap his way through any problems Kenan, Kel, or Mother sends his way. Join us as we celebrate his crowning grocer moments at... Rigby's! Email us at: kenankelpodcast@gmail.com Check out our T-Shirts: https://www.teepublic.com/user/kenan-kel-podcast And our Website: https://www.podpage.com/kenankelpodcast/ Twitter/Instagram/TikTok: @kenankelpodcast --- Send in a voice message: https://anchor.fm/kenankelpodcast/message

Blue Skies Podcast with Erin O'Toole, MP
The Need for a National Security Strategy with Vincent Rigby and Thomas Juneau

Blue Skies Podcast with Erin O'Toole, MP

Play Episode Listen Later Jul 31, 2022 57:04


MP Erin O'Toole is joined by Vincent Rigby and Thomas Juneau co-chairs of “A National Security Strategy for the 2020s” – a ground-breaking report evaluating the threat environment for Canada and recommending a clear strategy to counter these threats. Vincent Rigby is the former national security and intelligence advisor to the Prime Minister and Dr. Thomas Juneau is an associate professor at the University of Ottawa specializing in public safety and security issues. Rigby and Juneau discuss current threats to Canada including both foreign and domestic threats, disinformation, and the need for executive attention to the evolving threat environment. Their full report can be found here: https://socialsciences.uottawa.ca/public-international-affairs/ns2022en Like, subscribe, and engage your friends on this topic and the Blue Skies political podcast.

Munsons at the Movies
Ep. 67 - John Turturro (feat. Dames Marvs)

Munsons at the Movies

Play Episode Listen Later Jul 28, 2022 106:59


Welcome to the Munsons at the Movies podcast. Each episode we delve into the filmography and impact of a randomly selected actor. In this episode, we explore the career of John Turturro. Best known his roles as Jesus Quintana in The Big Lebowski (1998), Pete in O Brother, Where Art Thou (2000), and Barton Fink (1991), Turturro is one of the most versatile actors in Hollywood. Joined once again by Dames Marvs of Loch 22 Productions, we do our best to survive without Rigby by discussing how Turturro inspired a former President's relationship, his numerous projects with filmmakers like Spike Lee, the Coen Brothers, and Adam Sandler, his performances in the non-athletic sports movies, and why he's so underrated but appreciated by the Munsons and his peers. Where does Turturro rank on the Munson Meter? Listen to find out.

Pending Nuptials
Episode 4: It's Baby Time, Ya'll

Pending Nuptials

Play Episode Listen Later Jul 27, 2022 35:54


Ben and Kate give an update on their pregnancy, and pending induction. The clock is up, and baby Rigby is on its way!

Pending Nuptials
Episode 4: It's Baby Time, Ya'll

Pending Nuptials

Play Episode Listen Later Jul 27, 2022 35:54


Ben and Kate give an update on their pregnancy, and pending induction. The clock is up, and baby Rigby is on its way!

MoneyBall Medicine
Rare-X Wants to Build the Data Infrastructure for Rare Disease Research

MoneyBall Medicine

Play Episode Listen Later Jul 19, 2022 57:20


For people with common health problems like diabetes or high blood pressure or high cholesterol, progress in pharmaceuticals has worked wonders and extended lifespans enormously. But there's another category of people who tend to get overlooked by the drug industry: patients with rare genetic disorders that affect only one in a thousand or one in two thousand people. If you add up all the different rare genetic disorders known to medicine, it's a very large number; Harry's guest this week, Charlene Son Rigby, says there may be as many as 10,000 separate genetic disorders affecting as many as 30 million people in the United States and 350 million people worldwide. That's a lot of people who are being underserved by the medical establishment.Rigby is the head of a new non-profit organization called Rare-X that's trying to tackle a systematic problem that affects everyone with a rare disease: Data. In the rare disease world, Rigby says, data collection is so inconsistent that each effort to understand and treat a specific disease feels like reinventing the wheel. For longtime listeners of the show, that's a familiar story. Time and again, Harry has talked with people who point out the harms of storing patient data in separate formats in separate silos, and who have new ideas for ways to break down the walls between these silos. Rare-X is trying to do exactly that for the rare disease world, by building what Rigby calls a federated, cloud-based, cross-disorder data sharing platform. The basic idea is to take the burden of data management off of rare disease patients and their families and create a single central repository that can help accelerate drug development.Harry talked with Rigby about the challenges involved in that work, how it gets funded, how soon it might start to benefit patients, and what it might mean in a near-future world where every child's genome is screened at birth for potential mutations that could lead to the discovery of rare medical disorders.Please rate and review The Harry Glorikian Show on Apple Podcasts! Here's how to do that from an iPhone, iPad, or iPod touch:1. Open the Podcasts app on your iPhone, iPad, or Mac. 2. Navigate to The Harry Glorikian Show podcast. You can find it by searching for it or selecting it from your library. Just note that you'll have to go to the series page which shows all the episodes, not just the page for a single episode.3. Scroll down to find the subhead titled "Ratings & Reviews."4. Under one of the highlighted reviews, select "Write a Review."5. Next, select a star rating at the top — you have the option of choosing between one and five stars. 6. Using the text box at the top, write a title for your review. Then, in the lower text box, write your review. Your review can be up to 300 words long.7. Once you've finished, select "Send" or "Save" in the top-right corner. 8. If you've never left a podcast review before, enter a nickname. Your nickname will be displayed next to any reviews you leave from here on out. 9. After selecting a nickname, tap OK. Your review may not be immediately visible.That's it! Thanks so much.TranscriptHarry Glorikian: Hello. I'm Harry Glorikian, and this is The Harry Glorikian Show, where we explore how technology is changing everything we know about healthcare.For people with common health problems like diabetes or high blood pressure or high cholesterol, pharmaceuticals has worked wonders and extended lifespans enormously.But there's another category of people who tend to get overlooked by the drug industry.And that's patients with rare genetic disorders.By definition, rare diseases are rare, meaning they might only affect one in a thousand or one in two thousand people. But here's the thing. If you add up all the different rare genetic disorders known to medicine, it's a very large number.My guest today, Charlene Son Rigby, says there may be as many as 10,000 separate disorders affecting small populations.And if you count everyone who has these conditions, it may add up to as many as 30 million people in the United States and 350 million people worldwide.That's a lot of people who are being underserved by the medical establishment.And Rigby is the head of a new non-profit organization called Rare-X that's trying to fix that.Now, there are a lot of rare disease organizations that are looking for a cure for a specific condition.Rigby actually came to Rare-X from one of those, the STXBP1 Foundation, which is searching for a treatment for a rare neurological condition that affects Rigby's own daughter Juno.But Rare-X is a little different. It's trying to tackle a systematic problem that affects everyone with a rare disease. The problem is data.Rigby says that in the rare disease world, data collection is so inconsistent that each effort to understand and treat a specific disease feels like reinventing the wheel. For longtime listeners, that'll be a very familiar story.Time and again I've talked with people who point out the harms of storing patient data in separate formats in separate silos, and who have new ideas for ways to break down the walls between these silos. Rare-X is trying to do exactly that for the rare disease world, by building what Rigby calls a federated, cloud-based, cross-disorder data sharing platform.The basic idea is to take the burden of data management off of rare disease patients and their families and create a single central repository that can help accelerate drug development.I talked with Rigby about the challenges involved in that work, how it gets funded, how soon it might start to benefit patients, and what it might mean in a near-future world where every child's genome is screened at birth for potential mutations that could lead to the discovery of rare medical disorders.Here's our full conversation.Harry Glorikian: Charlene, welcome to the show.Charlene Son Rigby: Thanks. Nice to be here, Harry.Harry Glorikian: So I've been reading about what you guys are doing. I mean, all of it sounds super exciting. I'm, you know, been looking into this space for a long time from a rare disease, but many different angles of it. But can you just start off, tell us a little bit about yourself and how you got active in this world of rare disease research?Charlene Son Rigby: Yeah, thanks for that question. So I've spent most of my career building scalable software solutions for analyzing big data, and that's been both in health care as well as enterprise software. And so I'm now the CEO at Rare-X where we're building a platform to analyze rare disease data cross-disorder. And prior to being at Rare-X, I was the chief business officer at a company called Fabric Genomics, where we developed artificial intelligence approaches to speed diagnosis of patients through genomics. We had a considerable focus on rare disease and contributed to projects like the 100,000 Genomes Project and also the work that Stephen Kingsmore is doing at Rady Children's with diagnosing critically ill newborns in the NICU. And so when I started at Fabric, my daughter Juno was ten weeks old. She's my second child. And it was kind of a fortuitous timing, in some ways kismet, because at when I started at Fabric, I didn't know that she was going to start experiencing issues with her development. But at around four months she started missing milestones. And that started us on a three and a half year journey to find an answer to what was going on with her. And so during that time, we went through many, many tests, including genetic tests, MRIs, all kinds of all kinds of things, and everything kept coming back as negative or inconclusive. And so I was working at a genomics company, and so I kept pushing for whole exome testing, which at that time was still not, not readily available clinically and by insurance was still considered experimental. So we were denied three times, until we finally were able to get authorization in 2015. And so in early 2016, we got my daughter's diagnosis and she has a mutation in a gene that's involved in communication between neurons and the genes called STXBP1.Charlene Son Rigby: And so it's very rare. Thirteen kids born a day somewhere in the world. So thinking about Juno and thinking about this from a science standpoint, that it was pretty interesting that when she was diagnosed because she didn't have a classic phenotype for STXBP1. So most kids, 90% of the kids have seizures. And she has more of the symptoms around developmental delay, low muscle tone, cognitive issues and delayed walking and motor issues. And, you know, this this kind of challenge around these atypical phenotypes, I think, is actually becoming much more common in disease generally, so in rare disease and also more broadly in more common conditions as we're really starting to understand kind of the true breadth of patients. So in terms of your original question about my journey through rare disease, so I went on to co-found the STXBP1 Foundation to accelerate the development of therapies for kids like my daughter. And then coming to Rare-X was really a kind of joining of my software background with my passion for rare disease and really wanting to do something more broadly for the rare disease community.Harry Glorikian: I have to tell you, like what you said, three and a half years, I'm like, oh, my God. Like, I would be I have so many stories. And like when I was at Applied Biosystems and, you know, we're doing all this work. It just boggles the mind that some of these things are not really readily available to help get over that diagnostic odyssey for especially parents, because you're going to do anything to help your child. I'm glad it's actually moving theoretically faster these days. I'm not sure if insurance has actually kept up, but we're, on the technology side, I know we're everybody's pushing the envelope now. But when we talk about rare disease and you did some of the numbers but we hear about these rare diseases, I think a lot of people think of like there's an n of 1, right? They assume that this disease only affects a tiny number of people. Right. Maybe just one or a handful worldwide. But I mean, the fact is, if you add up all these different rare genetic diseases that exist in the human population, the number of people is actually pretty big. I mean, can you sort of. Put that into some sort of scale for us in what you've seen.Charlene Son Rigby: Yeah, you're absolutely right. You know, rare disease is by definition rare. And so it's easy in some ways to be dismissive of a rare disease because, oh, it's only affecting a few people. And it's true that a single rare disease can affect a very small number of people, even down to the n of 1 case that you talked about. From a definition standpoint, so, in the US, rare disease is defined as a disease affecting fewer than 200,000 Americans. And in Europe, in the EU, it's defined as affecting no more than one in 2,000 people. So we even though for ultra rare or n of 1 diseases, we can be talking about a small number of people, or like in my daughter's disorder, we can be talking about low thousands, there are still thousands of rare diseases and the traditional number that we hear a lot is 7,000. So 7,000 rare diseases. Rare-X is about to come out with some research that indicates that there are over 10,000 individual rare diseases, and this is really due to our growing understanding of genetics. So previously we might have grouped together a set of disorders based on what the symptoms were like. But now we understand that those actually are due to a different genetic etiology or different cause at a genetic level. And so if you aggregate all of those people up, across those 10,000 rare diseases, you know, what we're looking at is one in ten, potentially one in ten people in the world. And so in the US that's about 30 million people and in total 350 million people worldwide. So it's really a huge number of people. And from an impact standpoint, it's staggering when you look at the impact from a health care standpoint and from an economic standpoint.Harry Glorikian: Yeah, I mean, if you can diagnose, I mean, if there is a way to treat someone, then you get to it faster. And the economic impact is huge and unfortunately, if there isn't, maybe it spurs a pharmaceutical company to, you know, start working on it or figure out a way to treat that patient better. But at least you, I always tell people, the better the diagnosis, the better the next step. I see people sometimes, it seems like they're throwing a dart, you know, and they're it's an educated guess, but it's not, you know, the accurate diagnosis that you'd like to have. So. But how and where, when was sort of Rare-X born and what are you trying to do with the organization? What do you want to fix?Charlene Son Rigby: Yeah. So Rare-X was a pandemic baby. The organization was started in early 2020 and I just joined the organization last year. But, you know, it's really been quite a journey being able to have the, launch the platform during COVID. And I know we can talk about that in a little bit, but the unsolved problem that we are working to address is really around collecting data for rare disease. And one might ask, well, why is this an issue? I'll give an example. From the early days of the STXBP1 Foundation. W e assembled our scientific advisory board and we got together for our first scientific meeting. And we were going to develop our roadmap so that that would guide our priorities in terms of scientific development. And we were all very focused on therapies. So my expectation going into the meeting was we were going to talk about all the mice models we were going to build. What did we need to do in the lab? How are we going to get to that first therapeutic candidate? And the number one priority that came out of that meeting was to build a prospective regulatory-compliant natural history study. And so it was a huge learning for me because if you look at the kind of canonical steps in terms of drug development, it's always preclinical and then you move into clinical. And what I think that kind of simple model misses is this foundational layer around the data that you need and the real kind of understanding of the symptoms and the disease progression that is critical to building effective therapies, developing effective therapies.Charlene Son Rigby: And so that's really what Rare-X was started to do, was to enable the gathering of this data, the structuring of this data and enable it to be shared and to do this at scale. So, cross-disorder. And there are several problems today that that make this challenging. And so maybe I can talk a little bit about that. There are three or four of these significant challenges. So today some of this data does exist, but it's often kind of trapped in data silos. So it was generated in an individual project that might have happened in academia or industry. And then the data is often really only accessible to the group that collected it. And in rare disease where we don't have that many patients, it really makes it challenging to create a kind of more comprehensive understanding and picture of the patients if that data is trapped in these individual silos. Charlene Son Rigby: Another challenge that that we've seen is the lack of usable data. So individual studies may not include the key data that's needed to drive drug development forward. So some of these data repositories, they might either be a symptom specific. So they're looking at a specific organ system that might have been of interest to that researcher. So they're an incomplete picture. Or some of these repositories or these registries were started by passionate parents. You talked about that, the urgency that one feels as a parent, that I feel as a parent. And the registry may have been structured or the questions may have been structured in a way that isn't necessarily immediately usable by researchers because of the fact that it was started by a parent who, like you, you might not have had a statistical analysis background, you might not have had a survey methodology background. And we so those can be challenges in terms of having the data be robust and usable later. Charlene Son Rigby: And then the other thing that can be challenging and probably is often the most challenging is, is especially in these very, very new diseases, there's no data, and it takes quite a bit of funding to start data collection. Often, often passionate parents are going around trying to get researchers interested in their disorder. But it's often that you have to have a little bit of data to get a researcher interested. And so this is a huge challenge in terms of implementing data collection. And the other thing that kind of underlies this is that patients often are not empowered in this process. And so that was a fundamental piece of the way that we've structured Rare-X and the way that we collect data and the way that we enable patients to participate in the process to power data collection.Harry Glorikian: Yeah. I mean, it's, you know, they make movies out of this, right? People trying to push this boulder up a hill. So, what are the new ideas that say Rare-X is bringing to the table? I mean, your organization has called for like, you know, the largest data collection and federated data system and analysis platform in rare disease. So, I think unpacking that statement because it's a big statement, right, of, you know, what are you doing to improve data collection? What do you mean by federated, for those people that are listening? And why is it important? A  nd how will the platform enable better analysis of this rare disease data?Charlene Son Rigby: Yeah. Great question. From a design perspective, the one of the things that we wanted to do was make sure that the platform was cross-disorder. So a lot of registries are started for an individual disorder. And what we really wanted to be able to do was given that number of 10,000 diseases, how do we scale to support so many disorders to accelerate therapies? And so a fundamental design principle was to do that cross- disorder. The other piece of this is that we are focused on patient-reported data. So typically a participant will join the research program, create an account on the platform and they are either a patient or a caregiver of a patient and providing information on their symptoms. There is a lot of other data out there in the ecosystem that could come from other related registries, or it could come from clinical data, it could come from many different types of studies. And so we really want to enable the aggregation of or federation of that data. So you asked me to define that term. It really means bringing together multiple different data sets in a way that enables those data sets to be analyzed together. And I think, again, going back to this theme that for any individual rare disorder, there aren't that many patients. And so analyzing that data, kind of individually, we are really missing the opportunity to maximally use the data that's been contributed by rare disease patients. And I would even argue that it's a moral imperative for us to do that as a rare disease community, because we urgently need to move these understanding of these disorders forward in development of therapies as well.Harry Glorikian: I almost wish I could take all the companies I know doing this and put them there so the n goes up for everybody. But I know that there's all sorts of reasons that that doesn't happen. But, you know, when you were saying we're pulling in patient-reported data, you know, the first thing, and we talk a lot about this from different groups on the show is, you know, would a wearable or one of these other devices that are now available give you more granular, real- time information that might be valuable to this sort of study. And have you guys considered things like that?Charlene Son Rigby: T he short answer is yes, because the our desire is to really continue to expand the types of data that are collected. And the I think that the nice thing about mobile, mobile devices, wearables, is that it makes it very easy to collect that data. And so we have a partnership with Huma. They do work in the mobile space. And we're definitely continuing to evaluate where we can develop partnerships there. I mean, our goal overall is to de- burden patients and so that the, if we can do that in a way that additive to an overall body of research, then we're huge proponents of it. And I think that it's also important that we're really trying to create an open system. So our partnership model is a very, very open partnership model in terms of who we can work with.Harry Glorikian: Yeah, I had a really extensive conversation with the head of data sciences at WHOOP yesterday and you know, they're pulling in somewhere between 50 and 100 megabytes of data per patient per day. I shouldn't say patient -- per individual per day. Right. I was like, that's a lot of data. And she was, you know, the kid in a candy store because they're she's like, we can really see what's happening with people. And you can ask questions at a scale that you couldn't ask before. Like she was saying, you know, the last one of the things that we're working on publishing is 300,000 people. You couldn't imagine that in the world of, say, a clinical trial of 300,000 people are just going to, you know, and you have all the data, almost 24/7 on this person that's delivered by this device, which is sort of interesting, you know, place to be. So, you know, I know that you don't have 300,000 people in one in one area, but it'd be interesting to have that sort of 24/7 data available from these kids if you could, you know, get a device that would lend itself to that. But what stage is the company at in building the platform and you know, I guess the killer question is, when will drug developers or other researchers be able to start using it? If they already are, do you have any early success stories you can share?Charlene Son Rigby: Yeah, yeah. It's really a very exciting time at Rare-X. So the platform launched last summer and we have over 25 communities on the platform. And those encompass several hundred participants already. So we're really starting to see some exciting numbers in terms of in terms of participants. So we are launching our researcher portal at the end of Q2. So very soon. And at that point, any researcher, so academic researchers, pharma researchers, will be able to access the data and be able to utilize analytical tools to really interrogate the data. I'm excited that we also have launched our first sponsored program, and that's with Travere. They're supporting the homocystinuria community to start data collection, to start a registry. And we just launched that at the end of February.Harry Glorikian: So I want to. Jump back, like just talking through some of the biggest technical challenges along the way. I mean I know one of your goals is like interconnecting all these disparate data sources. But one of the issues that always comes up is how do you clean up that that existing data so that you can store it all the same way. And then obviously that enables somebody to then do the analytics right after that. But the biggest issue that I hear from a lot of people is, man, it takes a lot of effort to make sure that that data is cleaned up and put in the right place.Charlene Son Rigby: Yes, the data munging. Yeah. I mean, I think that that is really the, a significant challenge, because creating research-ready data and then harmonizing data sets is a huge amount of upfront work that has to happen before you can actually do any of the analysis and the data mining. So what we have done with the core data that's being generated within Rare-X is that we have mapped it to data standards. So we utilize standards like the human phenotype ontology, OMIM, HL7, so that the data that we're producing already is mapped to all of these generally utilized standards. And then we would if we were working on a federation project, the same thing would need to happen with these other data sets to really enable that type of integrated that type of integrated analysis. And you're right, it's it can be a very brute force effort in terms of doing it accurately. And that's why I think that it's really important from a from an industry perspective to really start adopting these standards and putting them into the base model, you know, for assuming just making the assumption up front that the data is going to be federated and utilized downstream. I think that kind of traditional studies, a lot of the scope was more really looked at in terms of what are we doing with the data today? And we need to be really thinking about from a lifetime perspective, how is this data going to be used?[musical interlude]Harry Glorikian: Let's pause the conversation for a minute to talk about one small but important thing you can do, to help keep the podcast going. And that's leave a rating and a review for the show on Apple Podcasts.All you have to do is open the Apple Podcasts app on your smartphone, search for The Harry Glorikian Show, and scroll down to the Ratings & Reviews section. Tap the stars to rate the show, and then tap the link that says Write a Review to leave your comments. It'll only take a minute, but you'll be doing a lot to help other listeners discover the show.And one more thing. If you like the interviews we do here on the show I know you'll like my new book, The Future You: How Artificial Intelligence Can Help You Get Healthier, Stress Less, and Live Longer.It's a friendly and accessible tour of all the ways today's information technologies are helping us diagnose diseases faster, treat them more precisely, and create personalized diet and exercise programs to prevent them in the first place.The book is now available in print and ebook formats. Just go to Amazon or Barnes & Noble and search for The Future You by Harry Glorikian.And now, back to the show.[musical interlude]Harry Glorikian: Now if we go one step before like getting that data, I mean. I have to imagine there's a huge political, bureaucratic or organizational challenge when it comes to who controls that data. And I think I have to assume,  part of your job is convincing them to share it, right, despite its potential as intellectual property. Right. So how do you get on the phone and say, “Why don't you press send and shoot that over to me and so that we can take the next steps with it?”Charlene Son Rigby: Yeah, well, this is a really significant challenge, and I think that we're in a time of change in terms of attitudes around this. And part of it is what's been happening in terms of national programs to collect data. And people are starting to see the benefit of being able to share and really utilize these larger data sets. But the reality today is that in terms of the status quo, researchers control the data, and that's because the data was generated in a specific project that might have happened in academia or in industry. And there's a challenge with alignment of incentives. So on the academic side, I think that if one were to ask a researcher, do they want to hoard data, they don't want to hoard data. But the reality is, is that we still have this challenge with academic tenure and needing to publish or perish in that environment. And so researchers are still rightly concerned because of that paradigm that they have to write their paper and get their paper in before they can feel comfortable with allowing others to access the data. And so something really needs to happen there to that incentive system. Charlene Son Rigby: And in pharma, interestingly, I think that that's also an area where there has been a feeling that data is almost akin to intellectual property. But I think that especially in rare disease, there has been a growing understanding that accessing natural history data is not going to, at the end of the day, enable pharma to win because they're going to win on the quality of their therapeutic pipeline and how quickly they can get those therapies through to a successful market approval. And so what we've been really working to do is position natural history data as pre-competitive and for rare disease, frankly, it's too expensive to build these data sets, you know, alone. They're, as we scale to all of these disorders it's going to become untenable to for each company to build their own data set. The thing that we need to do and what Rare-X has been working to do with our collaborators is to transform the way that research has been done and initiated and break down these barriers and just show that the model of building these pre-competitive collaborations can work, both from a how does the business model work and then how is the data shared? And so I think that Rare-X being a nonprofit and a kind of neutral third party is really additive in terms of building those relationships so that this, this kind of public-private partnership model can really serve as a way to drive this type of change.Harry Glorikian: Now. Okay. So we've talked about industry sharing data, but I always I mean, especially in the last maybe 5 to 10 years, I keep thinking about, you know, how much of this comes directly or will come directly from patients, right? If they have control or access to their data, they have the ability, theoretically, the ability to then share that data. Right. And it could be just for the research in general as opposed to, not specifically to find a cure for a specific disease. So how do you get that data or convince patients to share it?Charlene Son Rigby: Yeah, well, I think that in in rare disease patients are typically highly motivated. You know, there are many rare diseases that can be pretty devastating in terms of the symptoms and the disease progression. And so overall, there is a a good portion of the rare disease population that is motivated to provide their data. And so what we do there and I think that that your points about the paradigms and thinking about it, that the patients are sharing their data, is really important. Because I think that that gets lost a lot. You know, a patient, and we've all signed up for some research study in our lives. You go and you fill out a survey or you contribute a blood sample or something, but oftentimes the patient contributions get forgotten because it becomes part of the researcher's data set. And so the what we're really trying to do is turn around that kind of paradigm with a core principle that patients are the ones who own their data and they're contributing their data. And so we enable them to, through an innovative consent process, we enable them to basically say that, yes, they're willing to share their data for these types of projects, and they can change that at any time. And we really feel that that changes the paradigm and allows them to have a real seat at the table. And then I wanted to also talk about, because obviously not everyone is — there is this proportion of folks who are motivated and trust and that's part of the reason that they will be willing to share their data — but there is also a portion of the population that might not be as motivated. And so it's important for us to be able to reach those populations and to build trust in the approach that we're taking and the value of it in terms of really being able to drive research. And so patient education is an important component of our model patient education, patient engagement. So we work directly with patient advocacy organizations and patient advocates to educate their communities on the value of data collection, how it really spurs and supports research. I think that that's a critical component to this as well.Harry Glorikian: Well, hopefully people will listen to this podcast worldwide and me that may spur someone to search you guys up on the web. But I noticed that another principle of the company is you don't sell patient data, right? Does that mean you're giving it away? And if that is true, what's the criteria of doing that? And do your data partners that you're giving it to have to meet certain standards?Charlene Son Rigby: Yeah, this is a great question because monetization models around data are very, very common today. Some companies have built significant valuations around data monetization. And for from a Rare-X standpoint, and this is part of the reason why we were started, is that the question was asked like, is that the right thing to do, especially for diseases where we're in the very early stages of understanding a disorder, and so I talked about this a little bit earlier, that if you have no data, getting any researcher interested is already then a huge challenge. And so we're here really to break down barriers to advancing rare disease research and encourage that research. And so I say sometimes that it's really important that we free the data. So we don't sell data at Rare-X. And we have an open access model for researchers to access the data. Charlene Son Rigby: And so there it is not, “we open the doors and anybody can come, come and access the data.” It's done in a responsible way. So one of the key things is that the data is de-identified. And so it is it is critical to do that, because we want the data to be utilized for research. It doesn't need to have identifiable information in it to drive that research forward. You know, the second thing is, is that researchers need to submit information on their project, and then that's reviewed by a data access committee. And the idea behind this data access committee is not to slow down things. It's a streamlined and efficient process. But the idea is that there is a review process. The researchers need to specify whether there's an IRB with whether that protocol has gone through an institutional review board review, and patients can opt to only have their data. As an example, patients can opt to only have their data shared with projects that have gone through IRB review. So there's really kind of a, since this is in many ways a two sided platform, there's really a way that patients can actively engage in terms of who's accessing their data. And then the researchers also in terms of the types of projects that they're that they're going to put forward.Harry Glorikian: Okay. So now you're giving away the data. Remember, I'm a venture capitalist, so you're giving away the data, right? First question somebody like me asks is, how do you pay for the operations? I mean, you're building this fairly sophisticated system that is, you know, you've got to clean the data, you've got to make it available. You're trying to talk to all these people. I mean, are you funded by let's say, I mean the typical stuff, grants? Is it member donations? Is it major gifts from individuals? You know, those are all the questions that that would cross my mind.Charlene Son Rigby: Yeah, absolutely. So frankly, it took me some time to get my arms around this, because my whole career has been in tech and venture backed companies. And so so I took some time to really think about this and think about this scalable model from a scalability standpoint before joining. So we get our funding largely through pharma and industry, as well as some grants. And the way that that funding happens is, it's basically platform investment. And I think that this is a really key thing from my perspective of, of thinking about the, the platform as something that is, if you will, a social good. Because they're investing in expanding the platform. They might invest, like Travere did, additionally to help to onboard specific groups or expand our capabilities in terms of being able to gather data in a particular disease area. But the funding that they're providing is to make the platform and the research program more robust. The data at the back end will be open in the way that we've we have talked about it. We have a unique ability to do that and create that kind of model as a nonprofit. And you're right that what we're doing, we're kind of blending this health tech company with this this nonprofit  tmodel. But I think that there are some good examples out there of public private partnerships that have been very successful in the long term in doing this. And that's the model that we're really pursuing.Harry Glorikian: This area is small. I feel like I've been in and around it for a long time because of, you know, being in and around genomics. But there's a small but sort of growing infrastructure of support for rare disease, you know, patients in the world, sort of nonprofits, NGOs, patient advocacy group. Tthere's Global Genes, right? There's the Rare and Undiagnosed Network, RUN. There's the Undiagnosed Disease Network Foundation, and then there's the n-Lorem Foundation. And so many others that I don't want to leave out, right, the long list. But how does your, or, does your group overlap with these? I mean, I was reading a press release that this summer you guys will launch a collaboration with RUN and the Undiagnosed Disease Network Foundation to launch something called the Undiagnosed Data Collection Program. I mean, if you could sort of talk about what that project is about. Is your real ambition to be the data infrastructure sharing platform for the entire community of rare disease patients and families?Charlene Son Rigby: Yeah, well, I love that you call it infrastructure because I think this is critical from a concept standpoint. Rare disease should not be a model where each rare disease is doing it on its own. That was one thing that really struck me, thinking again about my daughter's disorder, where we were looking at ways to ladder up to that prospective natural history study. And we were trying to do something. I talked to a few other genetic neurodevelopmental conditions that were kind of our cohort, if you will, and we were all doing it in different ways. And it's such an opportunity cost to be figuring out the model new each time. And so these groups like Global Genes, amazing organization, actually, the Rare-X founder, Nicole Boyce, was also the founder of Global Genes. And we were, the STXBP1 Foundation used every single resource possible that came out of Global Genes. You know, that there's this broad this really broad education and enablement that needs to happen for people who want to become rare disease advocates. And that Global Genes has really done that in a tremendous way for so many organizations and so many individuals. And so we partner with them in terms of, and are very complementary, in terms of providing that infrastructure where Rare-X is focused on this area of how do you accelerate research through data collection, and then we use that.Charlene Son Rigby: It's great that you saw the announcement on the work that we're doing with RUN and the UDNF. I'm particularly excited about this because Rare-X, we talked earlier about ultra rare diseases, about n of 1 diseases. The reason why Rare-X is able to collect data across all of these disorders is that we have a fundamental assumption in the way that we collect data, which is that we don't assume that anybody does or does not have any symptoms. So we start out with a very high level, head to toe type of set of questions that if you say yes to any of them, it leads into a more detailed set of questions to collect data on particular symptoms. And so this is really ideally suited to situations where there isn't a lot of characterization around or understanding of the symptoms in a disorder and where you don't have a diagnosis. Because then what we're really enabling an individual to do is to gather robust data about their individual symptoms and disease progression that then can be utilized for research. And so we're very excited about being able to work with and support RUN and UDNF in in that effort. Charlene Son Rigby: And so do we have, you asked about ambition? You know, do we have a goal of being the only data sharing platform? I would say that our goal is to be an incredibly robust comprehensive cross- disorder platform. We believe that the way that we are approaching things really is enabling us to support all rare diseases. And we're really focused on de- burdening patients. So we're enabling patient communities to get started very quickly. And they don't have to become experts in protocol development, they don't have to become experts in creating clinical outcome assessments, etc. At the same time, the world is large and that they're going to be groups who decide that they need specific solutions. They may want to take on the role of being a principal investigator, as an example. And so I think that that's also the reason why federation is an important component of what we're really bringing forward as a as a way to bring all of that data together.Harry Glorikian: So again, you know, being on the venture side, right. You can lead a horse to water, but you can't make them drink, right? So you can do a lot. You can improve clinical trial readiness. You can make sure the data is better about rare disease patients, and that it's available. But you can't force the drug discovery companies or the drug makers to sort of develop a cure for a specific disease. Right. How do you think about that as part of a rare disease problem? Is that is that part of the work that Rare-X is,are you making it less risky so that they are willing to take that next leap?Charlene Son Rigby: You're right that pharma is going to be making, I would say, rational business decisions based on commercial drivers. And the challenge with a lot of rare diseases is that no one knows about that individual rare disease, and there isn't much data on it. And so anything that can be done to de-risk that process for a pharma company  is huge in terms of increasing their interest or generating interest for them and then increasing their interest. And those things can include knowing that there's an activated community, you know, because if you have a clinical trial and nobody wants to participate in the clinical trial, that's going to be a huge problem in terms of being able to get that drug through an approval process. And so Rare-X, by building a very robust data set, is able to de-risk that process in terms of that investment, of trying to understand what the disorder is and also trying rto understand disease progression. And going back to that point about activation of the community, we're also able to help to demonstrate the activation of the community because of the number of people participating in the in the data collection.Harry Glorikian: I know it's not science fiction. I think it's right around the corner, hopefully, but I think, isn't an ideal future where we do either whole-exome or preferably whole genome on every newborn and scan for these genetic changes that are associated with rare diseases. I mean, I'm assuming that would really push this area much farther along. And if that is true, if that statement is true, how long do you think it'll take for us to get there?Charlene Son Rigby: Wow. You're reminding me of the Gattaca movie, but hopefully that's not the real future for us, you know. Winding things back. So my daughter was born, my daughter Juno was born in 2013. So that's nine years ago. And it took three years for us to get a diagnosis. And, you know, that's like an entire other podcast. But I think that the really, if we fast forward to 2022, we have groups like Stephen Kingsmore's group at Rady Children's where they're diagnosing newborns who are in the NICU, in less than 24 hours. And even standard exome testing, which it took us three months to get our results, the standard exome testing results are now returned in less than two weeks. You can also get it faster if you have an urgent testing and we have the tech. Illumina has long been dominant and continues to be dominant in the clinical area. But you have these new entrants with Oxford Nanopore, Element, Singular, and there are others that are entering now. And so these costs are coming down and this is really going to be a transformative in terms of becoming, I do think that this is going to become standard of care and it's closer than we think. I think that it's probably going to be in the next ten years, less than ten years.Charlene Son Rigby: We already have some analogs to this in terms of or precursors, I should say, in terms of newborn screening. And so what I think is going to happen is that genomic sequencing is is going to become a core newborn screening tool. And the interesting thing is that there are applications, not just in rare disease, but also in common conditions and the value of genomic sequencing. So today, 5% of rare diseases have a therapy, but there are right now hundreds of gene therapies that are currently in preclinical and clinical pipeline. So this picture is going to change enormously in the next five years. And so because the value of is going to grow, because there are therapies, the other important thing is therapeutic windows. So therapeutic windows are when we can intervene to have the most impact on a disorder. And so that's often when someone's young before the symptoms present or start or very early in that process. And so I think that this is going to become a reality in the next decade. And frankly, I think it's a very exciting time. I have always been a big believer that knowledge is power. And this is this is one of those great situations where we have the ability to do something because we know.Harry Glorikian: Yeah, I talk about some of this in my book and there's some, you know, interesting stories and it's a fascinating time. And when I think back, you know, to when we first started sequencing and people would say, why would you want to sequence anything? And now it's the complete opposite. And the price is coming down. It's becoming easier and faster. And I mean, at some point, I think the price is going to be low enough between the actual sequencing and then the analysis, that as my friend says, it's going to be a nothingburger. I mean, it's just going to be like, yeah, we should just do that because it gives us the information we need for the next step, which is sort of going to be interesting.Charlene Son Rigby: Yeah, absolutely. I think that the that is the challenges that I talked about, cost of sequencing. But you're right that, you know, the analysis is still quite expensive today. And that's something that we're also going to need to need to improve. I mean, AI and the growing knowledge bases is really going to help to address that. Yeah. And but that's a huge component of it as well today. Absolutely.Harry Glorikian: Yeah. I'm looking at a company that in this particular area of oncology, they've gotten the whole genome analytics down to about $60. So it's, you know, it's coming to a point where you're like, why wouldn't you do that? Like, what's stopping you from doing that? So it's been great having you. Great conversation. I wish you guys incredible success. A nd I'd love to keep up on how things are going with the organization.Charlene Son Rigby: That'd be great, Harry. Really enjoyed it today. Thanks.Harry Glorikian: Thank you.Harry Glorikian: That's it for this week's episode. You can find a full transcript of this episode as well as the full archive of episodes of The Harry Glorikian Show and MoneyBall Medicine at our website. Just go to glorikian.com and click on the tab Podcasts.I'd like to thank our listeners for boosting The Harry Glorikian Show into the top three percent of global podcasts.If you want to be sure to get every new episode of the show automatically, be sure to open Apple Podcasts or your favorite podcast player and hit follow or subscribe.Don't forget to leave us a rating and review on Apple Podcasts. And we always love to hear from listeners on Twitter, where you can find me at hglorikian.Thanks for listening, stay healthy, and be sure to tune in two weeks from now for our next interview.

BYU-Idaho Radio
A new game store comes to Rexburg with big plans

BYU-Idaho Radio

Play Episode Listen Later Jul 11, 2022 10:57


Holidae Fun & Games is a new game store in Rexburg that has something for everybody from family-centered board game nights, to competitive trading card games, and even Dungeons and Dragons. “Magic The Gathering has three days right now Tuesday, Wednesday, Thursday, and then we have Pokémon on Thursday nights, and then we have My Hero Academia on Tuesday nights. We are trying to find a day for Yu-Gi-Oh, and Dungeons and Dragons is on Saturdays. Boardgames is all day any day,” said Jarek Smith in an interview with BYU-Idaho Radio. The store was a result of a need in Rigby that fit with Smith's love for board games and blossomed into a business after he and his wife saw there were no toy stores in Rigby. “We took our daughter and walked around all of Rigby and decided that the only store that's not around anywhere is a toy store,” Smith said. Smith was fond of board games as a child but was introduced to the world-building and atmospheric presentation of more niche games while in high school after a co-worker brought him to a game night with some other friends where they played games like Betrayal at House on the Hill. Now Smith has big plans for expanding the stores including the potential to host a crepe café. “The plan is crepes, ok? So sweet and savory crepes … so were are going to do that and soft-serve ice cream,” Smith said. You can learn more about Holidae Fun & Games by visiting their website here: https://www.holidaeshop.com/

Business Innovators Radio
Interview with Scott Rigby Ph.D, Behavioral Scientist, Author & Creator of the MotivationWorks Platform-Personalized Employee Engagement

Business Innovators Radio

Play Episode Listen Later Jun 29, 2022 24:35


Scott Rigby, Ph.D. is a behavioral scientist, author, and founder/CEO of Immersyve Inc., a company dedicated to applying behavioral science to improve experiences, well-being, and performance. Scott and Immersyve work with both small and large companies on motivational best practices, emphasizing the quantitative measurement of motivation and engagement using proven and actionable models. Scott is the co-creator of motivationWorks (motivationWorks.com), an innovative platform to drive greater wellness, performance, and engagement through the proven principles of Self-Determination Theory.Learn more: https://immersyve.com/https://motivationworks.com/Influential Entrepreneurs with Mike Saundershttps://businessinnovatorsradio.com/influential-entrepreneurs-with-mike-saunders/Source: https://businessinnovatorsradio.com/interview-with-scott-rigby-ph-d-behavioral-scientist-author-creator-of-the-motivationworks-platform-personalized-employee-engagement

Influential Entrepreneurs with Mike Saunders, MBA
Interview with Scott Rigby Ph.D, Behavioral Scientist, Author & Creator of the MotivationWorks Platform-Personalized Employee Engagement

Influential Entrepreneurs with Mike Saunders, MBA

Play Episode Listen Later Jun 29, 2022 24:35


Scott Rigby, Ph.D. is a behavioral scientist, author, and founder/CEO of Immersyve Inc., a company dedicated to applying behavioral science to improve experiences, well-being, and performance. Scott and Immersyve work with both small and large companies on motivational best practices, emphasizing the quantitative measurement of motivation and engagement using proven and actionable models. Scott is the co-creator of motivationWorks (motivationWorks.com), an innovative platform to drive greater wellness, performance, and engagement through the proven principles of Self-Determination Theory.Learn more: https://immersyve.com/https://motivationworks.com/Influential Entrepreneurs with Mike Saundershttps://businessinnovatorsradio.com/influential-entrepreneurs-with-mike-saunders/Source: https://businessinnovatorsradio.com/interview-with-scott-rigby-ph-d-behavioral-scientist-author-creator-of-the-motivationworks-platform-personalized-employee-engagement

SoL-Mates: Love and MST3K
The Oozing Skull (Cinematic Titanic) and Healthy Boundaries

SoL-Mates: Love and MST3K

Play Episode Listen Later Jun 28, 2022 73:56


We're dipping back in to the Cinematic Titanic world with the franchises first-ever movie, The Oozing Skull! It's terrible!Host segments: You know, golf buddies.; no pranking allowed; a Rigby 10; What even is this movie?; host segment vs. interstitials; Tracy's composition.cw: ethnic slur

BYU-Idaho Radio
Morning Headlines For June 24th 2022

BYU-Idaho Radio

Play Episode Listen Later Jun 24, 2022 2:43


Morning Headlines For June 24th 2022 covers the sentencing of a woman who attempted to murder her husband, programs to offset the property tax in Idaho and a new fitness center in Rigby.

Tasmania Talks with Brian Carlton
Luke Rigby, Healthy Male Case Study

Tasmania Talks with Brian Carlton

Play Episode Listen Later Jun 14, 2022 7:58


Luke Rigby, Healthy Male Case Study

BYU-Idaho Radio
Morning Headlines For June 14, 2022

BYU-Idaho Radio

Play Episode Listen Later Jun 14, 2022 3:25


Your Morning Headlines on this Tuesday... A man missing for nearly a week has been found safe. Plus, the city of Rigby is looking a new police chief. Also, the Extravadance event is starting this evening.

Hard Knox Talks
Police Shot my Son: The Story of Carey Rigby-Wilcox and Her Son Steven.

Hard Knox Talks

Play Episode Listen Later Jun 11, 2022 79:10 Transcription Available


Check out our upcoming live streams and find us on your favorite audio platform. Click the link and start exploring!https://linktr.ee/hardknoxtalks-----------------------------------------------------------------------“Good days are guilt, I feel like I killed my son because I called the cops, and they shot him.”Carey lost her son in 2018. Substance use and mental health were at the root of it all.“Nobody believed us, he was so intoxicated at the emergency room after a suicide attempt and they just gave him more meds and released him.”Attempt, after attempt it seemed help was nowhere to be found. All the doctors would do is prescribe and prescribe until one day the insanity came to a boiling point.“He didn't have time to talk, he just wanted to say goodbye. We were catching him trying to commit suicide all the time. He was just out of the psych ward a day and a half and he had a gun to his head. We called the cops. And now he's gone."Join us this week and listen to Carey #takeofftheblinders around our broken health care system.We'll talk about how Steven ended up using substances, how he met his ultimate demise, and what Carey intends to do about all this to try and prevent this from happening again.We stand in respect this week as Carey takes the stage in the hopes to educate the masses about what is really happening out there this week, on Hard Knox Talks.Buckle up.#addiction #suicideawareness 

A VGM Journey
Level 101: Masters of VGM

A VGM Journey

Play Episode Listen Later Jun 11, 2022 72:27


Water Town - Shantae - Jake Kaufman Fighting With All of Our Might - Shovel Knight - Jake Kaufman Area 1 Spaceship - Regular Show: Mordercai & Rigby in 8-Bit Land - Jake Kaufman Jive Bot - Mighty Switch Force - Jake Kaufman Ken's Theme - Street Fighter II - Yoko Shimomura Seeing Dreams Through the Window of the Stars - Super Mario RPG: Legend of the Seven Stars - Yoko Shimomura Valse di Fantastica - Final Fantasy XV - Yoko Shimomura Mysteries of the Cave - Mario & Luigi: Dream Team - Yoko Shimomura Mission Briefing - Time Trax - Tim Follin BGM 1 - Silver Surfer - Tim and Geoff Follin Beach - Plok - Tim and Geoff Follin Main Theme - Ghouls N Ghosts - Tim Follin Everything is Going to Be Okay - Prey - Mick Gordon Faust - Lawbreakers - Mick Gordon The Only Thing They Fear is You - Doom Eternal - Mick Gordon Ransacked - Wolfenstein: The New Order - Mick Gordon Check out the Masters of VGM website!!!

Medicare for All
Livin' On a Prayer: Health Care Sharing Ministries

Medicare for All

Play Episode Listen Later Jun 10, 2022 33:02


Today we look at the somehow-legal world of healthcare sharing ministries, a form of health coverage where like-minded religious folks share health care costs. After a series of lawsuits and scandals, these companies are in the news again recently. We'll look at what HCSMs are, how they have flourished as insurance costs rise, and the potential risks they pose to the unsuspecting consumer. Then we'll turn the page to talk about how communities of faith are playing a key role in winning a just and equitable healthcare system. Today we look at the somehow-legal world of healthcare sharing ministries, a form of health coverage where like-minded religious folks share health care costs. After a series of lawsuits and scandals, these companies are in the news again recently. We'll look at what HCSMs are, how they have flourished as insurance costs rise, and the potential risks they pose to the unsuspecting consumer. Then we'll turn the page to talk about how communities of faith are playing a key role in winning a just and equitable healthcare system. Our guest today is the Reverend Jim Rigby. Rev. Rigby has been the pastor at St. Andrew's Presbyterian Church in Austin Texas for over 25 years. He has a love of world religions and a passion for social justice. Healthcare justice has been a part of his ministry because he believes that healthcare is the most basic right to life, along with a living wage and decent housing. https://www.youtube.com/watch?v=GeRIN9nF-to Show Notes What are Health Care Sharing Ministries? Ben explains that healthcare sharing ministries (HCSMs) are a form of health coverage in which members, who share religious beliefs, make monthly payments to cover the healthcare costs of other members. BUT they are not insurance. Insurance is supposed to cover most of your healthcare services, with cost-sharing by the patient. HCSM are much cheaper than insurance, which is why they're so alluring. But they cover much less, and only pay for a fixed amount of a service, regardless of the total cost. HCSMs, unlike insurance companies, don't take on any risk. The ministries are typically Christian. Members generally must declare their religious faith and promise not to smoke, drink alcohol excessively, or engage in extramarital sexual activity. Generally, they also do not cover abortion, mental health services, or birth control. Unlike insurance, HCSMs can deny coverage for people with pre-existing conditions. The ACA used to fine people for not having insurnace, but HCSMs were exempted from that fine even though they do not meet the federal definition of insurance. (That fine was eliminated under the Trump administration, and the Biden administration hasn't reinstated it.) HCSMs have been around since the 80s, but grew in popularity during the 90s and again after the passage of Obamacare – basically whenever we see concerted efforts to make the government responsible for more healthcare costs. “About 1.5 million Americans are members of these kinds of ministries, according to the Alliance of Health Care Sharing. Some $2 billion in medical expenses were shared through this type of ministry in 2020.  There are over 100 health sharing organizations certified by the U.S. Department of Health and Human Services for meeting the federal law's definition of a health sharing ministry.” – Reported in Catholic World Report in May 2022. Unregulated HCSMs leave people behind and contradict the religious values they claim to be based on Health insurance companies aren't well-regulated in the United States, but they still have to operate under some basic regulations. Gillian explains that there are virtually no regulations on HCSMs. As a result their practices can be exploitative. Thirty states actually have “safe harbor” rules that exempt HCSMs from the restrictions on insurance companies. In “safe harbor” states, as long as members receive a written disclaimer from the HCSM...

LA Theatre Bites - Podcast
McCoy Rigby Entertainment presents : In the Heights @ La Mirada Theatre for the Performing Arts

LA Theatre Bites - Podcast

Play Episode Listen Later Jun 6, 2022 3:06


McCoy Rigby Entertainment presents: In the Heights @ La Mirada Theatre for the Performing Arts – Review 10 out of 10 - A Masterpiece! LA Theatre Bites Recommended. www.latheatrebites.com

BGMania: A Video Game Music Podcast
Classical Music in Games

BGMania: A Video Game Music Podcast

Play Episode Listen Later Jun 5, 2022 61:07


Episode #237 of BGMania: A Video Game Music Podcast. ALERT! We have something that's never happened before on the show... Bryan is not in this episode! This week on the show, Bedroth from RPGera presents a solo sister episode to the "Licensed Songs Used Expertly in Games" show from two weeks ago and explores a much more different side of music... the Classical kind! Email the show at bgmaniapodcast@gmail.com with requests for upcoming episodes, questions, feedback, comments, concerns, whatever you want really! Special thanks to our Executive Producers: Jexak & Xancu. EPISODE PLAYLIST AND CREDITS Music #1 (The Nutcracker Ballet: Dance of the Sugar Plum Fairy) from Tetris [Hirokazu "Hip" Tanaka / Pyotr Ilyich Tchaikovsky, 1989] Run! Run! Run! (William Tell Overture: Finale: March of the Swiss Soldiers) from Gokujou Parodius! Kako no Eikou wo Motomete [Kazuhiro Senoo / Gioachino Antonio Rossini, 1994] Just Dig! (Orphée aux Enfers: Galop Infernal) from Lemmings [Tomomi Hatakeyama / Jacques Offenbach, 1992] Turkish March (Piano Sonata No. 11: Alla turca) from Donkey Konga [Junko Ozawa / Wolfgang Amadeus Mozart, 2003] Pachelbel's Canon (Canon in D) from Ane-San [Koji Hayama / Johann Pachelbel, 1995] Bonus Gallery (String Quintet in E major, Op. 11, No. 5: Minuetto) from Regular Show: Mordecai & Rigby in 8-Bit Land [Jake Kaufman / Ridolfo Luigi Boccherini, 2013] Frantic Factory/Action Type B (Csiko's Post) from Yoshi's Cookie [Akira Satou, Nobuya Ikuta, or Noriko Nishizaka / Hermann Necke, 1993] Palace of Gods (Toccata & Fugue in D minor) from Battle of Olympus [Kazuo Sawa / Johann Sebastian Bach, 1989] Docking Sequence (An der schönen, blauen Donau: The Blue Danube) from Elite [Aidan Bell & Julie Dunn / Johann Baptist Strauss II, 1984] Moonlight Sonata (Piano Sonata No. 14: Sonata quasi una fantasia) from Resident Evil Remake [Shusaku Uchiyama, Makoto Tomozawa, or Misao Senbongi / Ludwig van Beethoven, 2002] Germany Stage: Wolfgang Krauser's Theme (Requiem in D minor: Dies irae) from Fatal Fury 2 [Toshio Shimizu / Wolfgang Amadeus Mozart, 1992] Ave Maria (Opus 52, No. 6: Ellens dritter Gesang) from Hitman: Blood Money [Jesper Kyd / Franz Peter Schubert feat. Daniel Perret of the Zurich Boys' Choir, 2006] G-Senjou no Aria #5 (Orchestral Suite no. 3 in D major: Second movement: Air on the G String) from G-senjou no Maou -The Devil on G-string- [tiko-μ / Johann Sebastian Bach, 2009] Planets Suite "Mars", "Jupiter" (The Planets: Mars, the Bringer of War and Jupiter, the Bringer of Jollity) from Catherine [Shoji Meguro / Gustav Theodore Holst, 2011] SUPPORT US Patreon: https://patreon.com/rpgera CONTACT US Website: https://rpgera.com Discord: https://discord.gg/cC73Heu Twitch: https://twitch.tv/leveldowngames Twitter: https://twitter.com/OriginalLDG Instagram: https://instagram.com/bryan.ldg/ Facebook: https://facebook.com/leveldowngaming --- Send in a voice message: https://anchor.fm/bgmania/message

Holding the Ladder in Sport and Leadership
Episode #65- Chanda Rigby, head women's basketball coach, Troy University, Troy, AL

Holding the Ladder in Sport and Leadership

Play Episode Listen Later May 30, 2022 43:00


Chanda Rigby is entering her 11th season at Troy University in 2022-23. She has built the Trojans into the premier program in the Sun Belt Conference, winning five championships in seven years. Since taking over the program in 2012, Rigby has made Troy a perennial championship, and National Collegiate Athletic Association (NCAA) Tournament, contender. Rigby's impressive resume includes seven 20+ win seasons, three Sun Belt Tournament Championships, two Sun Belt Regular Season Titles, three trips to the NCAA Tournament, six postseason appearances, 20 all-conference selections, five Sun Belt Post Season Award winners, a Sun Belt Player of the Year honoree and a Sun Belt Coach of the Year honor. Before taking over the Trojan program in 2012-13, Rigby spent 12 years at the junior college level. She spent seven seasons at Pensacola State where she coached three Women's Basketball Coaches Association (WBCA) All-Americans as well as one McDonald's All-American and four National Junior College Athletic Association (NJCAA) All-Americans. She guided the Pirates to a combined 64-6 record over the last two seasons with two trips to the NJCAA Final Four and earned two third-place finishes. Before Pensacola State, Rigby led Holmes Community College to four straight winning seasons and spent one season at National Association of Intercollegiate Athletics (NAIA) member Tabor College where she transformed a last-place team into one of the top teams in the conference. Rigby began her head coaching career at Northwest Rankin High School in Mississippi in 1992 before returning to her home state of Louisiana to coach at Loranger High School from 1996-2000. Rigby graduated from Southeastern Louisiana University with a bachelor's degree in English education in 1990 and a master's degree in secondary education in 1998. She earned her doctorate in higher education leadership from Nova Southeastern University in July of 2017. She is married to Ed Rigby, a high school football head coach and Athletic Director. The couple has two sons, Ramsey and Randon. Her contact information can be found here: https://troytrojans.com/staff-directory/chanda-rigby/178 --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app Support this podcast: https://anchor.fm/tim-rice4/support

Roy Green Show
Former National Security and Intelligence Advisor to the Prime Minister Vincent Rigby - Is Canada facing a National Security threat?

Roy Green Show

Play Episode Listen Later May 28, 2022 18:10


KNGI Network Podcast Master Feed
Viper's VGMture – E08 – A Fine Array (25 May 2022)

KNGI Network Podcast Master Feed

Play Episode Listen Later May 25, 2022


Moar variety! How about some picross, bullet hells, licensed games, shooters, Commodore 64 loaders, club remix albums and even more for your listening pleasure on tonight's VGMture? TRACKLISTING: 00:00:00 - Hatsune Miku Logic Paint S - Grow to Love 00:02:37 - NEO: The World Ends with You - Chase 00:06:13 - Welcome to Viper's VGMture 00:19:58 - Marble Saga: Kororinpa (Marbles! Balance Challenge) - Kororinpa Create 00:21:36 - Touhou Youyoumu ~ Perfect Cherry Blossom. - The Capital City of Flowers in the Sky 00:29:43 - You're Listening to Viper's VGMture 00:43:27 - Ocean Software - Ocean Loader #4 00:46:25 - Regular Show: Mordecai and Rigby in 8-Bit Land - Area 1 - Top - Down 00:49:48 - This is Viper's VGMture 01:15:50 - DOOM Eternal - The Only Thing They Fear Is You 01:22:36 - Chocobo GP - The Man with Six Arms 01:24:32 - You're Locked in to Viper's VGMture 01:36:56 - The Legend of Heroes: Kuro no Kiseki - Rise of the GRENDEL 01:39:13 - MARIO KART 64 on CLUB CIRCUIT - Circuit 01:43:29 - Thanks for Listening! 01:49:56 - Astral Chain - Savior (Long Version)

Advance Movement Podcast
Plenary 1 - Rigby Wallace - The Two Frontiers Of The Gospel

Advance Movement Podcast

Play Episode Listen Later May 23, 2022 40:08


Audio recordings of the sessions from the Advance Global Gathering, which took place in May 2022, in Bournemouth, UK.

Scared To Death
"Shhhh..."

Scared To Death

Play Episode Listen Later May 11, 2022 80:08 Very Popular


SCARED TO DEATH IS EXPLICIT IN EVERY WAY. PLEASE TAKE CARE WHILE LISTENING First, we head back to one of America's favorite haunted places, Savannah, Georgia. Today we visit the Olde Harbour Inn, where a creepy, seemingly male ghost, likes to crawl into bed with female guests. A very disturbing modern encounter story to accompany some lore. Then, we head to one of America's oldest city, St Augustine, Florida, to share legends and encounters that accompany it's supposedly haunted lighthouse. Third, the tale of Mrs. Rigby, a heart warming ghost who loves to make herself known by whistling. Lastly, an archeologist exploring an abandoned root cellar in Texas is in for a real surprise!New Merch: Brand new matching Crystal Mom and Crystal Baby tees are now available in the bad magic store. Awesome design featuring 25 precious and semi precious gems. There's Amethyst, Citrine, Amber! Go to badmagicmerch.com and scoop up your new t-shirt! Standup: Also - if you want to see a very different side of Dan than you see here, his Symphony of Insanity standup tour is back and running. Go to dancummins.tv for ticket links to shows in Chicago, Salt Lake City, Missouri, Milwaukee and Davenport this spring.Bad Magic Productions Monthly Patreon Donation:  So excited to announce this months charity, The HALO Dental Network. Our donation amount to HALO is $14,300 with another $1600 being set aside for the Cummins Family Scholarship. More info coming on the scholarship in a few months! HALO was founded by Dr. Brady Smith. The HALO Dental Network is a coalition of dental professionals who donate their services to the dental under served. Services include dental implants, veneers, fillings and crowns. If you want to learn more, please visit halodentalnetwork.org. Not only can donate you can also nominate someone you know who is in need. Thank you for continuing to send in your stories, Creeps and Peepers! Please keep doing so. Send them to mystory@scaredtodeathpodcast.com  Send everything else to info@scaredtodeathpodcast.comWant to be a Patron? Get episodes AD-FREE, listen and watch before they are released to anyone else, bonus episodes, a 20% merch discount, additional content, and more! Learn more by visiting: https://www.patreon.com/scaredtodeathpodcastPlease rate, review, and subscribe anywhere you listen. Thank you for listening! Follow the show on social media: @scaredtodeathpodcast on Facebook and IGWatch this episode on Youtube: https://youtu.be/g8jpXsSI4l0Website: https://scaredtodeathpodcast.com/Facebook: https://www.facebook.com/scaredtodeathpodcast/Instagram: https://bit.ly/2miPLf5Mailing Address:Scared to Deathc/o Timesuck PodcastPO Box 3891Coeur d'Alene, ID 83816Video/Audio by Bad Magic ProductionsAdditional music production by Jeffrey MontoyaAdditional music production by Zach CohenVarious free audio provided by http://freesound.orgOpening Sumerian protection spell (adapted): "Whether thou art a ghost that hath come from the earth, or a phantom of night that hath no home… or one that lieth dead in the desert… or a ghost unburied… or a demon or a ghoul… Whatever thou be until thou art removed… thou shalt find here no water to drink… Thou shalt not stretch forth thy hand to our own… Into our house enter thou not. Through our fence, breakthrough thou not… we are protected though we may be frightened.  Our life you may not steal, though we may feel SCARED TO DEATH."

Comedy Slab
196 - Mum's On The Run

Comedy Slab

Play Episode Listen Later May 10, 2022 45:36


This week we review Mum's On The Run (Series 1 Episode 1)Sitcom starring Ronni Ancona as single mum Jen and John Gordon-Sinclair as Mr Rigby.Mum's On The Run follows Jen's hectic life as she finds herself spending most of her time as an unpaid chauffeur to her 14-year-old teenage existentialist son, Toby, and a tonally challenged harmonica practising 10-year-old daughter, Felicity.Meanwhile, she also has to cope with her jazz musician ex-husband, the fiercely competitive and annoying downstairs neighbour, and the huge crush she has on her son's history teacher.Written by Alex ZegermanProduced by Dawn Ellis & Alison Vernon-SmithA BBC Production.Mum's On The Run is available here: https://bbc.in/3s8wzje The Comedy Slab Podcast is available on Apple Podcasts, Spreaker, Stitcher, iHeart Radio, Spotify and Youtube. Subscribe for a new episode each Tuesday. Get in touch - we're @ComedySlab on Twitter and ComedySlab on Facebook.

BYU-Idaho Radio
Morning Headlines For May 6, 2022

BYU-Idaho Radio

Play Episode Listen Later May 6, 2022 4:04


Idaho residents to receive a small check from a settlement case, a new tiny homes business in Rigby is open, Iona City Hall receives a renovation, and INL develops a plan to achieve zero-carbon emissions by 2031.

Bad Dads Film Review
Sound of Metal & Regular Show

Bad Dads Film Review

Play Episode Listen Later Apr 29, 2022 89:33


Sidey is famed for his sartorial elegance so it should come as no surprise that he picked the Top 5 Suits for us to discuss. By the end of this week's show, you'll know your two-piece from your three-piece, your tuxedo from your dinner jacket and your shell suit from your tracksuit. SOUND OF METAL is director Darius Marder's 2019 story about Ruben, a drummer in the experimental heavy metal band Blackgammon and the impact of his devastating and sudden hearing loss on his ongoing issues with sobriety. Riz Ahmed was Oscar nominated for his portrayal and it's a transformational and powerful performance but it's supporting actor Paul Raci, himself the son of Deaf parents, who steals the movie as Vietnam veteran and recovering alcoholic Joe, the charismatic leader of the community. A rallying call not to treat individuals with disabilities as broken, waiting to be fixed, we all enjoyed this moving journey alongside the fascinating insights into the Deaf community and culture it also provides. As a father to two girls I've been subjected to more than my fair share of unicorns over the years and feel strongly that this week's kids feature, the animated series REGULAR SHOW, has it right: The Unicorns Have Got To Go, which is coincidentally the title of the episode we watched. Mordecai and Rigby find their friendship tested when Mordecai is more interested in buying new cologne 'Dudetime' in order to attract waitress Margaret than spending time with Rigby playing the latest exciting video game, Strong Johns. But when Mordecai sprays himself with the aftershave the only thing attracted to him is a group of douchebag unicorn bros, out for a good time and definitely not trying to trick you into drinking a cup of their suspiciously spermy looking cocktails. Soon things get out of hand; Rigby's trampoline gets broken and park manager Benson, a sentient gumball machine, appears to be sexually assaulted. Will the boys rid themselves of the hangers on and patch up their failing friendship inside 12 minutes?We love to hear from our listeners! By which I mean we tolerate it. Try us on twitter @dads_film, on Facebook Bad Dads Film Review or on our website baddadsfilm.com. Until next time, we remain... Bad Dads

ResumoCast | Segunda Temporada
T3#103 Ágil do jeito certo | Darrel Rigby, Sarah Elk, Steve Berez

ResumoCast | Segunda Temporada

Play Episode Listen Later Apr 18, 2022 32:15 Transcription Available


Muito se fala sobre os métodos ágeis hoje em dia e como eles têm o poder de transformar – para melhor – o modo como trabalhamos, trazendo inovação e avanços com mais rapidez e menor custo. Isso tudo é verdade. O problema é que, por ter se tornado uma palavra da moda, o ágil muitas vezes é aplicado de forma equivocada e repentina nas empresas, e o resultado é um grande caos: clientes nervosos, funcionários insatisfeitos e líderes colocados em xeque Em Ágil do jeito certo, três experientes e renomados consultores da Bain & Company explicam de forma clara as principais dificuldades dos gestores na hora de adotar o ágil e todas as armadilhas que eles podem vir a enfrentar. Utilizando exemplos de grandes empresas como Bosch, Amazon, Spotify e Dell, os autores vão ajudá-lo a iniciar sua jornada ágil evitando inúmeros erros já conhecidos – e vislumbrar um futuro de resultados cada vez melhores.   Entre para o Clube do Livro: https://www.resumocast.com.br/apoiase

Why Weight Elevate
Episode 54 Continuous Glucose Monitors (CGM)

Why Weight Elevate

Play Episode Listen Later Apr 13, 2022 14:45


In this 15 minute podcast Dr. Rigby and Quincy discuss Continuous Glucose Monitors (CGMs). The topics include: The two types of GCMs that are approved by US insurance companies: Libre and DEXCOM We discuss how they measure your body's sugar levels, and we compare them to the traditional finger pricks used to measure sugar levels. What are the benefits of using them? Are they covered by insurance?

Flip the Switch by EngageMint
The Core Principles Driving Employee Motivation w/ Dr. Scott Rigby

Flip the Switch by EngageMint

Play Episode Listen Later Apr 11, 2022 54:23


Salary increases and rewards have their place, but to inspire connection and tenure with your employees requires more. In this episode, David Millay and Dr. Scott Rigby, Founder and CEO of Immersyve and MotivationWorks, dive into self-determination theory, employees' three basic needs and the obstacles employers must overcome to motivate their teams long-term.  -----Show Notes2:41   Background on Immersyve 4:35   Self-Determination Theory6:33   Motivation Myths10:00   The Need to Believe14:12   The Need to Belong15:21   The Need to Succeed17:10   Connecting Purpose to Individual Tasks22:34   Obstacles to Creating a Space of Belonging 28:49   Overcoming Challenges to Succeed30:53   Promotions vs. Skill Growth33:38   The Fundamental Shift in Employee Engagement38:59   Motivating Employees Working Remotely42:09   “ROW” Workplaces44:03   Countering Arguments Against Reward Structures47:32   Rewards vs. Recognition51:15   Scott's Billboard-----For more information on the topics covered in this episode:Immersyve How to Stop Engagement Benchmarks from Hurting Employee EngagementThink Like Amazon: 50 1/2 Ideas to Become a Digital Leader by John RossmanConnect with Scott via email or on LinkedIn | Twitter 

Why Weight Elevate
Episode 52 A Discussion Regarding Fiber

Why Weight Elevate

Play Episode Listen Later Mar 25, 2022 7:02


It's colorectal cancer awareness month in the USA. In this 7 minute episode, we discuss the topic of fiber. Dr. Rigby shares his perspective on what fiber is, how much fiber a person should consume, and what foods help you consume healthy fiber.

The Unchosen Fork
The Truth About The Terrible Diet TM

The Unchosen Fork

Play Episode Listen Later Mar 25, 2022 34:38


Sarah finally discusses The Terrible Diet tm.  Otherwise known as the Autoimmune Protocol or AIP, Sarah covers how this radical approach to food has changed the course of her health, disease, and life.  Learn how the AIP process works, what a food coach is, and why vegan is not the answer for everyone.  Stay for why Sarah had to take a "sabbatical" to save her friendships. Join us on The Unchosen Fork.ReferencesMills, E.N.C., Sancho, A.I., Rigby, N.M., Jenkins, J.A. and Mackie, A.R. (2009), Impact of food processing on the structural and allergenic properties of food allergens. Mol. Nutr. Food Res., 53: 963-969. https://doi.org/10.1002/mnfr.200800236M.D., Wahls Terry. The Wahls Protocol: A Radical New Way to Treat All Chronic Autoimmune Conditions Using Paleo Principles. Illustrated, Avery, 2014. terrywahls.comM.D., Myers Amy. The Autoimmune Solution: Prevent and Reverse the Full Spectrum of Inflammatory Symptoms and Diseases. Reprint, HarperOne, 2017.  amymyersmd.comTam, Michelle, and Henry Fong. Nom Nom Paleo: Food for Humans (Volume 1). 1st Edition, Andrews McMeel Publishing, 2013. nomnompaleo.comAhmed, Serge H.a,b; Guillem, Karinea,b; Vandaele, Younaa,b Sugar addiction, Current Opinion in Clinical Nutrition and Metabolic Care: July 2013 - Volume 16 - Issue 4 - p 434-439 doi: 10.1097/MCO.0b013e328361c8b8 COSNES, J., et al. “Incidence of Autoimmune Diseases in Celiac Disease: Protective Effect of the Gluten-Free Diet.” Clinical Gastroenterology and Hepatology, vol. 6, no. 7, 2008, pp. 753–58. Crossref, https://doi.org/10.1016/j.cgh.2007.12.022.Follow the Unchosen Fork:FacebookInstagramDisclaimer: The contents of this podcast, including text, graphics, images, and other materials created and/or disseminated by The Unchosen Fork are for informational purposes only. The Contents are NOT intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health providers with any questions you may have regarding a medical condition, before beginning a nutritional plan and/or taking nutritional supplements. Reliance on any information provided by this podcast, others content appearing on this podcast, or other visitors to the Site is solely at your own risk. None of the contents of this podcast are intended to be relied upon for medical treatment or diagnosis. The Unchosen Fork, their affiliates, nor any of the host family members assumes any liability or responsibility for damage or injury to person or property arising from any use of any product, service, information, or instruction contained on this Podcast.Support the show (https://www.patreon.com/theunchosenfork)

The Stay Focused Podcast
SFP 139 How to Build an Engaged Community on Instagram An Interview With Stephy Rigby

The Stay Focused Podcast

Play Episode Listen Later Mar 23, 2022 28:46


Instagram making you want to pull your hair out a bit?  I mean really, we're photographers, why can't we just post our pretty pictures over on IG and call it a day. Stephy Rigby with @yourcontentbestie is chatting with me on the show today and sharing with you how to really build an Instagram community. We hone right in on the photography community and dive in to topics like: *how to see results on instagram when you have little time, *creating authentic content that converts *creating the perfect content mix for instagram (reels, anyone?) *how to create authentic content that isn't boring *AND how can you get results on instagram when you are strapped for time   This is an epsiode you don't want to miss! LINKS: https://cozyclicks.com/courses More of Stephy--> www.yourcontentbestie.com Grab Stephy's dream client guide--> https://view.flodesk.com/pages/6182f691db5bc2b4fb30848f  

The Marshfield Outdoors Podcast

Coming off the most amazing hunting trip for Bruno, the TEXAS sized Axis deer, I had the pleasure of sitting down with Trey Rigby, Founder of Axis Addict. Trey gives us some great insight on the axis deer of Texas, his awesome platform and preparing to hunt them. Trey even listens in on my recap of our big hunt that God surely blessed us on. Trey was a huge supporter of ours going into this hunt and I can now say I am lucky to have such a great friend in Trey down in Texas. Enjoy! @axisaddict 

Inspiring Futures
The Future of Transformation- Rachel Mercer and Mike Rigby- Proto

Inspiring Futures

Play Episode Listen Later Mar 10, 2022 60:35


Proto is a consultancy that was founded just over a year ago by some of the leadership of R/GA.'s business transformation unit. In the episode, I talk with Rachel Mercer- the Chief Experience Officer, and Mike Rigby- Chief Design Officer.The conversation covers their background and experience, the types of work that Proto is involved with, and the importance of clearly defining your own brand and living its values.It's a fascinating conversation that shows how creativity can move upstream in the world of consulting and how a valuable mix of skills and experience can help clients shift and transform their businesses for the digital age and beyond.